Physician Assistant · Houston, TX
NPI
1770992877
Since 2014
Specialty
Physician Assistant
Code 363A00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1515 Holcombe Blvd
Houston, TX, 77030
Phone (713) 792-6161
Medicare paid, 2024
$9,978
289 services
Medicare patients, 2024
227
Average age 73
Drug cost, 2024
$6.9M
819 prescriptions
Company payments, 2025
$18K
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Julie Huynh-Lu was code 99212 (office e&m - established), 102 times for 87 patients. In total Julie Huynh-Lu billed 289 services in 9 codes, and Medicare paid $9,978.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-02-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99212 Office E&M - Established | Facility | 102 | 87 | $22.01 | $2,245 |
| 38222 Other Organ Systems | Facility | 76 | 76 | $43.17 | $3,281 |
| 99213 Office E&M - Established | Facility | 68 | 58 | $43.89 | $2,984 |
| 99441 Telephone Services | Facility | 23 | 19 | $23.63 | $543 |
| 38220 Other Organ Systems | Facility | 11 | 11 | $36.93 | $406 |
By year: 2022 $6,243 for 158 services; 2023 $7,433 for 188 services; 2024 $9,978 for 289 services.
Medicare prescription drug claims, 2024
In 2024, the drug Julie Huynh-Lu prescribed most often to Medicare patients was Jakafi (Ruxolitinib Phosphate), with 125 prescriptions and refills. In total Julie Huynh-Lu wrote 819 Medicare prescriptions that cost $6.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Jakafi Ruxolitinib Phosphate | 125 | 125 | 24 | $2.2M |
| Valacyclovir Valacyclovir Hcl | 92 | 145 | 24 | $2,401 |
| Ojjaara Momelotinib Dihydrochloride | 53 | 53 | Under 11 | $1.4M |
| Sprycel Dasatinib | 32 | 32 | Under 11 | $219K |
| Tasigna Nilotinib Hcl | 31 | 31 | Under 11 | $392K |
| Imatinib Mesylate Generic | 25 | 25 | Under 11 | $65K |
| Levofloxacin Generic | 20 | 20 | Under 11 | $169 |
| Venclexta Venetoclax | 19 | 19 | Under 11 | $126K |
| Allopurinol Generic | 19 | 33 | Under 11 | $105 |
| Hydroxyurea Generic | 18 | 40 | Under 11 | $287 |
| Tramadol Hcl Generic | 17 | 17 | Under 11 | $148 |
| Potassium Chloride Generic | 16 | 32 | Under 11 | $282 |
| Imbruvica Ibrutinib | 14 | 18 | Under 11 | $150K |
| Calquence Acalabrutinib Maleate | 14 | 14 | Under 11 | $217K |
| Bosulif Bosutinib | 14 | 14 | Under 11 | $188K |
Brand drugs: 409 claims; generic drugs: 410 claims; opioid claims: 17.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Julie Huynh-Lu $18K ($18K in general payments such as food, travel and fees) from 16 companies. The largest payer was Incyte Corporation with $11K.
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation INCY | 27 | $11K |
| GlaxoSmithKline, LLC. GSK | 8 | $6,914 |
| W. L. Gore & Associates, Inc. | 1 | $126 |
| Sobi, Inc SOBI.ST | 3 | $87.34 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $84.06 |
| Lilly USA, LLC LLY | 2 | $62.05 |
| Abbvie Inc. ABBV | 2 | $58.66 |
| Pfizer Inc. PFE | 1 | $33.08 |
| Syndax Pharmaceuticals, Inc. SNDX | 1 | $31.97 |
| Rigel Pharmaceuticals, Inc. RIGL | 1 | $31.61 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.